ArticleOncoimmunology2022

MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.

Jinti Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.